Skip to main content
Top
Literature
1.
go back to reference Sgambat K, Banks M, Moudgil A (2013) Effect of galactose on glomerular permeability and proteinuria in steroid-resistant nephrotic syndrome. Pediatr Nephrol 28:2131–2135PubMedCrossRef Sgambat K, Banks M, Moudgil A (2013) Effect of galactose on glomerular permeability and proteinuria in steroid-resistant nephrotic syndrome. Pediatr Nephrol 28:2131–2135PubMedCrossRef
2.
go back to reference Mishra OP, Singh AK, Pohl M, Kumar B, Batra VV, Narayan G (2013) Oral galactose in children with focal and segmental glomerulosclerosis: a novel adjunct therapy. Clin Kidney J. doi:10.1093/ckj/sft147 Mishra OP, Singh AK, Pohl M, Kumar B, Batra VV, Narayan G (2013) Oral galactose in children with focal and segmental glomerulosclerosis: a novel adjunct therapy. Clin Kidney J. doi:10.​1093/​ckj/​sft147
3.
go back to reference Kopac M, Meglic A, Rus RR (2011) Partial remission of resistant nephrotic syndrome after oral galactose therapy. Ther Apher Dial 15:269–272PubMedCrossRef Kopac M, Meglic A, Rus RR (2011) Partial remission of resistant nephrotic syndrome after oral galactose therapy. Ther Apher Dial 15:269–272PubMedCrossRef
Metadata
Title
Galactose treatment in focal and segmental glomerulosclerosis
Authors
Om P. Mishra
Arun K. Singh
Publication date
01-05-2014
Publisher
Springer Berlin Heidelberg
Published in
Pediatric Nephrology / Issue 5/2014
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-013-2731-1

Other articles of this Issue 5/2014

Pediatric Nephrology 5/2014 Go to the issue